We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003465
Recruitment Status : Completed
First Posted : March 12, 2004
Last Update Posted : June 20, 2013
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Duke University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : February 2001